Why we do what we do.
Anemia affects more than 2 billion people worldwide annually.
Characterized by low hemoglobin, anemia affects 2 billion annually, including 83 million in the US.
Sanguina is focused on delivering affordable hemoglobin testing to populations who need it most.
(Source: Worldwide Prevalence of anemia 1993-2011, WHO 2015)
Let our research do the talking.
Want to also take part in Sanguina’s development?
Send us a message regarding partnership opportunities.